Works matching IS 2005-0380 AND VI 35 AND DT 2024
Results: 236
Erratum: Recent breakthroughs in the management of locally advanced and recurrent/metastatic cervical cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e118
- Publication type:
- Article
Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trial.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e117
- By:
- Publication type:
- Article
Salvage hysterectomy for persistent residual cervical cancer: assessment of prognostic factors.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e113
- By:
- Publication type:
- Article
A phase II trial evaluating the efficacy and safety of repeated high dose medroxyprogesterone acetate (MPA) therapy for patients with recurrent early-stage endometrial cancer or atypical endometrial hyperplasia: Japanese Gynecologic Oncology Group study (JGOG2051/KGOG2031, REMPA trial)
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e106
- By:
- Publication type:
- Article
Prevalence and prognostic value of PD-L1 expression and tumor mutational burden in persistent, recurrent, or metastatic cervical cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e105
- By:
- Publication type:
- Article
Unveiling pembrolizumab effectiveness in diverse subtypes of MSI-high endometrial cancers.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e103
- By:
- Publication type:
- Article
Genetic analysis of cervical cancer with lymph node metastasis.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e102
- By:
- Publication type:
- Article
The prognostic significance of primary tumor site in vulvar cancer: a population-based cohort study.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e101
- By:
- Publication type:
- Article
Efficacy and safety of combined anlotinib-oral etoposide treatment for patients with platinum-resistant ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e100
- By:
- Publication type:
- Article
Cost-effectiveness of pembrolizumab plus chemotherapy for advanced endometrial cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e86
- By:
- Publication type:
- Article
Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle-income country setting.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e85
- By:
- Publication type:
- Article
Prognostic values of tumor size and location in early stage endometrial cancer patients who received radiotherapy.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e84
- By:
- Publication type:
- Article
The effectiveness of CA125 and HE4 as clinical prognostic markers in epithelial ovarian cancer patients with BRCA mutation.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e80
- By:
- Publication type:
- Article
SLAMF7 predicts prognosis and correlates with immune infiltration in serous ovarian carcinoma.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e79
- By:
- Publication type:
- Article
Abnormal p53 expression is associated with poor outcomes in grade I or II, stage I, endometrioid carcinoma: a retrospective single-institute study.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e78
- By:
- Publication type:
- Article
QL1604 plus paclitaxel-cisplatin/carboplatin in patients with recurrent or metastatic cervical cancer: an open-label, single-arm, phase II trial.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e77
- By:
- Publication type:
- Article
A retrospective study of dose-dense paclitaxel and carboplatin plus bevacizumab as first-line treatment of advanced epithelial ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e76
- By:
- Publication type:
- Article
Influence of cancer in pregnancy on obstetric and neonatal outcomes: an observational retrospective cohort study.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e74
- By:
- Publication type:
- Article
Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with BRCA mutation and/or maintenance therapy.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e73
- By:
- Publication type:
- Article
Evaluation of clinical usefulness of HPV-16 and HPV-18 genotyping for cervical cancer screening.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e72
- By:
- Publication type:
- Article
Mirvetuximab soravtansine in platinum-resistant recurrent ovarian cancer with high folate receptor-alpha expression: a cost-effectiveness analysis.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e71
- By:
- Publication type:
- Article
CDK1 promotes the phosphorylation of KIFC1 to regulate the tumorgenicity of endometrial carcinoma.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e68
- By:
- Publication type:
- Article
Niraparib in Japanese patients with platinum-sensitive recurrent ovarian cancer: final results of a multicenter phase 2 study.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e115
- By:
- Publication type:
- Article
Step-by-step demonstration of "sciatic-nerve-preserved beyond-LEER" in a Thiel-embalmed cadaver: a novel salvage surgery for recurrent gynecologic malignancies.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e112
- By:
- Publication type:
- Article
First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e99
- By:
- Publication type:
- Article
Cost-effectiveness of atezolizumab plus chemotherapy for advanced/ recurrent endometrial cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e83
- By:
- Publication type:
- Article
Comprehensive characterization of genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC: a single center experience.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e69
- By:
- Publication type:
- Article
Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e114
- By:
- Publication type:
- Article
TET3-mediated DNA demethylation modification activates SHP2 expression to promote endometrial cancer progression through the EGFR/ERK pathway.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e64
- By:
- Publication type:
- Article
Patient and clinician priorities for information on treatment outcomes for advanced ovarian cancer: a Delphi exercise.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e63
- By:
- Publication type:
- Article
The efficacy of the levonorgestrel intrauterine system versus oral megestrol acetate in treating atypical endometrial hyperplasia: a superior randomized controlled trial.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e62
- By:
- Publication type:
- Article
Cost-effectiveness analysis of hospital treatment volume and survival outcomes in endometrial cancer in Japan.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e61
- By:
- Publication type:
- Article
Comparison of outcomes of laparotomic and minimally invasive radical hysterectomy in women with early-stage cervical cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e60
- By:
- Publication type:
- Article
The new 2023 FIGO staging system for endometrial cancer: what is different from the previous 2009 FIGO staging system?
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e59
- By:
- Publication type:
- Article
Cost-effectiveness of tisotumab vedotin as a second- or third-line therapy for cervical cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e58
- By:
- Publication type:
- Article
Therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer IIICr: a trial protocol for a phase III, multicenter, randomized controlled study (KGOG1047/DEBULK trial).
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e57
- By:
- Publication type:
- Article
HPV vaccination status and effectiveness in Korean women with HPV16/18 infection (2010-2021): a retrospective study.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e56
- By:
- Publication type:
- Article
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 4, p. 1, doi. 10.3802/jgo.2024.35.e111
- By:
- Publication type:
- Article
Response to: Author's reply to: Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 4, p. 1, doi. 10.3802/jgo.2024.35.e110
- By:
- Publication type:
- Article
Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis: comment.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 4, p. 1, doi. 10.3802/jgo.2024.35.e109
- By:
- Publication type:
- Article
The SHAPE trial: is good is good enough?
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 4, p. 1, doi. 10.3802/jgo.2024.35.e107
- By:
- Publication type:
- Article
Targeting BRAF pathway in low-grade serous ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 4, p. 1, doi. 10.3802/jgo.2024.35.e104
- By:
- Publication type:
- Article
The value of surgery and the prognostic factors for patients with recurrent low-grade endometrial stromal sarcoma: a retrospective study of 38 patients.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 4, p. 1, doi. 10.3802/jgo.2024.35.e98
- By:
- Publication type:
- Article
LncRNA STARD7-AS1 suppresses cervical cancer cell proliferation while promoting autophagy by regulating miR-31-5p/TXNIP axis to inactivate the mTOR signaling.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 4, p. 1, doi. 10.3802/jgo.2024.35.e97
- By:
- Publication type:
- Article
Clinical characteristics and status of treatment of small-cell carcinoma of the ovary, hypercalcemic type in the Chinese population: a meta-analysis.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 4, p. 1, doi. 10.3802/jgo.2024.35.e96
- By:
- Publication type:
- Article
Perioperative outcomes and platinum resistant recurrence in patients undergoing systematic, protocol-based, total parietal peritonectomy during interval cytoreductive surgery for advanced ovarian cancer: results of the TORPEDO study.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 4, p. 1, doi. 10.3802/jgo.2024.35.e95
- By:
- Publication type:
- Article
Correspondence on: The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter by Nicolai et al.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 4, p. 1, doi. 10.3802/jgo.2024.35.e91
- By:
- Publication type:
- Article
Bispecific immunotherapy MEDI5752 or volrustomig and cervical cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 4, p. 1, doi. 10.3802/jgo.2024.35.e82
- By:
- Publication type:
- Article
Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 4, p. 1, doi. 10.3802/jgo.2024.35.e75
- By:
- Publication type:
- Article
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 4, p. 1, doi. 10.3802/jgo.2024.35.e55
- By:
- Publication type:
- Article